drugset / Trial / NCT03525028

A Clinical Trial of Metformin to Decrease Glucocorticoids Side Effects in Patients With Autoimmune Uveitis

NCT03525028 ↗

RandomizedParallel-groupDouble-blindTreatment

Summary

This project is designed to evaluating the use of combination therapy of glucocorticoid and metformin to decrease glucocorticoid side effects in participants with autoimmune uveitis.This study also aims to evaluate the anti-inflammatory and immunosuppressive effects of combination therapy.

Timeline

Start
2018-11-01
Primary completion
2023-01-01
Completion
2023-01-01

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Metformin Small molecule 500 mg Oral

Indications